Article

Tumor Mutation Burden May be a Prognostic Biomarker of Long-Term Survival in Resected Small-Cell Lung Cancer

2020-10-16

Abstract excerpt

<h4>Background: </h4> Small cell lung cancer (SCLC) has a poor prognosis. The majority of SCLC patients do not survive within a few months of diagnosis, however, a sub-group of patients have a long-term survival. Individual differences in prognosis remain elusive. We present the first comprehensive comparative genomic profiling and tumor mutation burden (TMB) analyses of SCLC on patients with long-term survival (L...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 69bc82bd-9e11-5746-9d78-7a59dcdf0091
DOI: 10.21203/rs.3.rs-92277/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Tumor Mutation Burden May be a Prognostic Biomarker of Long-Term Survival in Resected Small-Cell Lung CancerDOI 10.21203/rs.3.rs-92277/v1Read

Comprehensive genomic profiling of small cell lung cancer in Chinese patients and the implications for therapeutic potentialSemantic proximity Read

Tumor Mutational Burden and Genomic Alterations in Chinese Small Cell Lung Cancer Measured by Whole-Exome Sequencing.Semantic proximity Read

Molecular subtyping of small-cell lung cancer based on mutational signatures with different genomic features and therapeutic strategies.Semantic proximity Read

Molecular subtyping of small cell lung cancer.Semantic proximity Read

SCLC-State of the Art and What Does the Future Have in Store?Semantic proximity Read

Genomic Features of Chinese Small Cell Lung CancerSemantic proximity Read

The landscape of tumor mutational burden and its clinical significance in patients with lung cancer: a Multi-omics study with a meta-analysisSemantic proximity Read

Prognostic value of tumor mutation burden in non-small cell lung cancer: A Meta-Analysis and system reviewSemantic proximity Read

Genetic Mutation Analysis in Small Cell Lung Cancer by a Novel NGS-Based Targeted Resequencing Gene Panel and Relation with Clinical Features.Semantic proximity Read

Molecular genetic profiling of small cell lung carcinoma in a Chinese cohortSemantic proximity Read

Small cell lung cancer: emerging subtypes, signaling pathways, and therapeutic vulnerabilitiesSemantic proximity Read

Recent progress in mapping the emerging landscape of the small-cell lung cancer genome.Semantic proximity Read